{"url_path":"/sec/avhhl/8-k/2026-05-14/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1762303/0001193125-26-224022-index.html","accession_number":"0001193125-26-224022","cik":"0001762303","ticker":"RCEL","issuer_name":"AVITA Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1762303/0001193125-26-224022-index.html","primary_entity_key":"0001762303","primary_entity_name":"AVITA Medical, Inc."},"word_count":112,"has_tables":true,"body_markdown":"Item 2.02 Results of Operations and Financial Condition.\n\nOn May 14, 2026, the Company issued a press release announcing its financial results for the first quarter ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.\n\nThe information furnished in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing."}